ZA200705213B - Nanoparticulate tacrolimus formulations - Google Patents

Nanoparticulate tacrolimus formulations

Info

Publication number
ZA200705213B
ZA200705213B ZA200705213A ZA200705213A ZA200705213B ZA 200705213 B ZA200705213 B ZA 200705213B ZA 200705213 A ZA200705213 A ZA 200705213A ZA 200705213 A ZA200705213 A ZA 200705213A ZA 200705213 B ZA200705213 B ZA 200705213B
Authority
ZA
South Africa
Prior art keywords
nanoparticulate tacrolimus
tacrolimus formulations
formulations
nanoparticulate
tacrolimus
Prior art date
Application number
ZA200705213A
Inventor
Scott Jenkins
Gary Liversidge
Elaine Liversidge
Original Assignee
Elan Pharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd
Publication of ZA200705213B publication Critical patent/ZA200705213B/en

Links

ZA200705213A 2004-12-15 2007-06-29 Nanoparticulate tacrolimus formulations ZA200705213B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63681704P 2004-12-15 2004-12-15

Publications (1)

Publication Number Publication Date
ZA200705213B true ZA200705213B (en) 2009-08-26

Family

ID=39129770

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705213A ZA200705213B (en) 2004-12-15 2007-06-29 Nanoparticulate tacrolimus formulations

Country Status (2)

Country Link
CN (1) CN101132768A (en)
ZA (1) ZA200705213B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2757979A1 (en) * 2009-04-09 2010-10-14 Alkermes Pharma Ireland Limited Controlled-release clozapine compositions
CN107823214A (en) * 2017-10-18 2018-03-23 江苏知原药业有限公司 Treat the composition of Immunoinflammatory Disorders
CN112121173B (en) * 2020-08-22 2022-05-06 浙江大学 Fatty acid modified immunosuppressant MMF and FK506 nano preparation and preparation method and application thereof
CN113425716A (en) * 2021-05-27 2021-09-24 南京诺亚药业有限公司 Tacrolimus pharmaceutical composition and preparation method thereof
CN116407499A (en) * 2021-12-29 2023-07-11 辅必成（上海）医药科技有限公司 Tacrolimus ophthalmic emulsion and preparation method thereof

Also Published As

Publication number Publication date
CN101132768A (en) 2008-02-27

Similar Documents

Publication Publication Date Title
IL183945A0 (en) Nanoparticulate tacrolimus formulations
IL183549A0 (en) Nanoparticulate benzothiophene formulations
ZA200710113B (en) Nanoparticulate clopidogrel formulations
IL183196A0 (en) Injectable nanoparticulate olanzapine formulations
IL184238A0 (en) Nanoparticulate candesartan formulations
IL181265A0 (en) Stabilizing formulations
ZA200708702B (en) Nanoparticulate quinazoline derivative formulations
EP1738806A4 (en) Ball
GB0423565D0 (en) Formulation
GB0412530D0 (en) Formulation
ZA200705213B (en) Nanoparticulate tacrolimus formulations
HK1076761A1 (en) Takraw balls
ZA200704086B (en) Antiinfective lipopeptides
IL183109A0 (en) Antiinfective lipopeptides
GB0406048D0 (en) Drug formulations
GB0506035D0 (en) Improved formulation
ZA200606977B (en) Alkaloid formulations
GB0402076D0 (en) Travel ease
AP2006003734A0 (en) Inhalation formulation
GB0417226D0 (en) Formulations
IL179208A0 (en) Intereferon formulations
GB0417248D0 (en) Formulations
GB0414443D0 (en) Castor
GB0401070D0 (en) Castor
HRP20040538A2 (en) Vitalisation ball